Tolerance Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IM Cannabis Corp : IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company

IM Cannabis Corp : IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTel avivAnna tarankoAdjupharm gmbOren shusterRonen twitoHoldings ltdCanadian securities exchangeTel aviv stock exchangeIm cannabis corpHolding companyExchange of securitiesHerbs ltdAr yarok pharm ltdKadimastem ltdTolerance inc

Kadimastem plans listing on Nasdaq through merger

The Israeli biotech stem cell company will delist from the TASE.

United statesTel avivMartin schlaff alphaJulien ruggieriRonen twitoAsaf shiloniIlex medical companyAdi wolf clover fundTolerance incTel aviv stock exchangeMichel revelWeizmann instituteMartin schlaffAlpha capitalAdi wolfClover wolf fund

iTolerance, Inc to Present at Biotech Showcase 2024

iTolerance, Inc to Present at Biotech Showcase 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoSusan robertsAnthony japourJenene thomasTolerance incChief executive officerBiotech showcase

iTolerance, Inc to Present at Biotech Showcase(TM) 2024

iTolerance, Inc to Present at Biotech Showcase(TM) 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesAnthony japourSusan robertsJenene thomasTolerance incChief executive officerBiotech showcase

iTolerance, Inc to Present at Biotech Showcase(TM) 2024

Live presentation on Monday, January 8th at 11:30 AM PTMIAMI, FL / ACCESSWIRE / January 4, 2024 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage, privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Dr. Anthon.

San franciscoUnited statesJenene thomasSusan robertsAnthony japourTolerance incChief executive officerBiotech showcase